Borosil Scientific Limited (BOM:544184)

Theseus Pharmaceuticals Revenue

In the fiscal year ending March 31, 2025, Borosil Scientific had annual revenue of 4.38B INR with 10.73% growth. Borosil Scientific had revenue of 1.29B in the quarter ending March 31, 2025, with 10.86% growth.

• Revenue: 4.38B
• Revenue Growth: +10.73%
• P/S Ratio: 3.23
• Revenue / Employee: 6.95M
• Employees: 631
• Market Cap: 14.15B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	4.38B	424.92M	10.73%
Mar 31, 2024	3.96B	2.98B	302.40%
Mar 31, 2023	984.08M	-80.23M	-7.54%
Mar 31, 2022	1.06B	410.30M	62.73%
Mar 31, 2021	654.02M	163.45M	33.32%